C
Citigroup Inc.
C's fundamentals are strong, but it looks expensive: trading at 12x earnings, above its usual 10x. Analysts expect strong earnings growth.
IREN
IREN Limited
There isn't enough reported data to score IREN yet.
C Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
C's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like C.
IREN Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Weak | |
| N/A | |
| N/A |
IREN's revenue and profitability are currently under pressure. Free cash flow and net leverage aren't meaningful measures for financial services companies like IREN.
C PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 6.3x | $64.83 | -48% |
| Fair | 9.8x | $101 | -19% |
| Forward | 10x | $124 | — |
| Current | 12x | $124 | — |
| Expensive | 16x | $164 | +32% |
Historical ranges are pointers, not guarantees.
C's PE is in its fair range at 12x. If earnings grow as analysts expect, today's price would be 10x next year's earnings.
IREN PE Valuation
IREN has no meaningful PE right now: it lost money over the past year.
C Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Moderate |
C has the edge over IREN on the outlook, with more favorable earnings expectations.
IREN Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses growing | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect IREN's losses to grow, with revenue growing. However, they disagree widely on these estimates.
C Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $12.18 | +19% |
| Q3 2026 | $10.27 | +44% |
| Q2 2026 | $9.28 | +37% |
| Q1 2026 | $8.09 | +28% |
| Q4 2025 | $6.99 | +18% |
| Q3 2025 | $7.11 | +103% |
| Q2 2025 | $6.76 | +87% |
| Q1 2025 | $6.32 | +84% |
| Q4 2024 | $5.94 | +47% |
C has the edge over IREN on earnings quality, reporting a profit while its opponent remains loss making.
IREN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$3.96 | -347% |
| Q2 2026 | -$2.22 | -988% |
| Q1 2026 | $0.51 | +$1.10 |
| Q4 2025 | $1.18 | +$1.62 |
| Q3 2025 | $1.60 | +$1.99 |
| Q2 2025 | $0.25 | +$0.45 |
| Q1 2025 | -$0.59 | -$0.43 |
| Q4 2024 | -$0.44 | -$0.15 |
IREN has swung to a loss: it lost $3.96 per share over the past year, after a profit the year before.
C Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $23.8B | +7.9% |
| Q2 2026 | $24.8B | +14% |
| Q1 2026 | $24.6B | +14% |
| Q4 2025 | $19.9B | +1.5% |
| Q3 2025 | $22.1B | +8.7% |
| Q2 2025 | $21.7B | +7.6% |
| Q1 2025 | $21.6B | +2.3% |
| Q4 2024 | $19.6B | +12% |
C's revenue has grown year over year for 10 quarters in a row: $23.8B last quarter, up 7.9% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 31% | +6.4 points |
| Q2 2026 | 32% | +8.3 points |
| Q1 2026 | 31% | +5.3 points |
| Q4 2025 | 19% | -0.2 points |
| Q3 2025 | 24% | +2.6 points |
| Q2 2025 | 24% | +2.7 points |
| Q1 2025 | 25% | +3.7 points |
| Q4 2024 | 19% | +32 points |
C has the edge over IREN on profitability, with a higher operating margin.
IREN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $228M | -5.1% |
| Q2 2026 | $137.2M | -27% |
| Q1 2026 | $144.8M | 0% |
| Q4 2025 | $184.7M | +59% |
| Q3 2025 | $240.3M | +355% |
| Q2 2025 | $187.3M | +230% |
| Q1 2025 | $144.8M | +168% |
| Q4 2024 | $116.1M | +176% |
IREN's revenue has held roughly level: $228M last quarter, down 5.1% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -82% | -50 points |
| Q2 2026 | -452% | -461 points |
| Q1 2026 | -161% | -180 points |
| Q4 2025 | -63% | -79 points |
| Q3 2025 | -32% | +57 points |
| Q2 2025 | 9% | +49 points |
| Q1 2025 | 19% | +8 points |
| Q4 2024 | 15% | +21 points |
IREN's operating margin was −82% last quarter, down 50 points from the same quarter a year ago.
C Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $22.3B | +$22.8B |
| Q2 2026 | -$25.6B | +$12.7B |
| Q1 2026 | -$23.3B | +$36.9B |
| Q4 2025 | $24.9B | +7.9% |
| Q3 2025 | -$517M | +$17.7B |
| Q2 2025 | -$38.3B | -$19.7B |
| Q1 2025 | -$60.2B | -$47.8B |
| Q4 2024 | $23.1B | +$29.5B |
C has the edge over IREN on cash flow, with more consistent year-over-year improvement.
IREN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1.6B | -$1.6B |
| Q2 2026 | $482.2M | +2895% |
| Q1 2026 | -$873.8M | -$523.1M |
| Q4 2025 | -$468M | -$334M |
| Q3 2025 | -$38M | +$349.4M |
| Q2 2025 | $16.1M | +$179M |
| Q1 2025 | -$350.7M | -$128.7M |
| Q4 2024 | -$134M | -$105.2M |
IREN's free cash flow was −$2.5B over the past year, against −$507M the year before. Free cash flow isn't a meaningful measure for financial services companies like IREN.
C Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1.7% | -29M shares |
| 1 year | -8.4% | -156M shares |
| 3 years | -13% | -245M shares |
| 5 years | -16% | -320M shares |
| Available history | -25% | -559M shares |
C has the edge over IREN on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $3B |
| Q2 2026 | $4B |
| Q1 2026 | $6.3B |
| Q4 2025 | $4.5B |
| Q3 2025 | $5B |
| Q2 2025 | $2B |
| Q1 2025 | $1.8B |
| Q4 2024 | $968M |
C spent $17.8B buying back its own shares over the past year, up 83% from the year before.
IREN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +26% | +82.4M shares |
| 1 year | +10% | +36.9M shares |
| 3 years | +511% | +333M shares |
| 5 years | +624% | +344M shares |
| Available history | +2346% | +382M shares |
IREN has 399M diluted shares, up 10% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
| Q2 2024 | — |
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
C Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 13.0x | High |
| Q2 2026 | 13.0x | High |
| Q1 2026 | 13.5x | High |
| Q4 2025 | 15.0x | High |
| Q3 2025 | 15.2x | High |
| Q2 2025 | 16.0x | High |
| Q1 2025 | 15.5x | High |
| Q4 2024 | 16.0x | High |
C's net debt is about 13 years of its operating earnings (EBITDA), down from 15 years a year ago. Net leverage isn't a meaningful measure for financial services companies like C.
IREN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2026 | 157.6x | High |
| Q4 2025 | 22.2x | High |
| Q3 2025 | 4.1x | High |
| Q2 2025 | 2.0x | Moderate |
| Q1 2025 | 3.3x | Elevated |
| Q4 2024 | -4.6x | Net Cash |
| Q3 2024 | -16.7x | Net Cash |
| Q2 2024 | -15.9x | Net Cash |
IREN's net debt is more than 20 years of its operating earnings (EBITDA), up from 3.3 years a year ago. Net leverage isn't a meaningful measure for financial services companies like IREN.
C Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 46.5 | Neutral |
| Stochastic | 16.5 | Oversold |
C's weekly RSI is 47 (neutral) and its Stochastic is 16 (oversold).
IREN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 33.3 | Neutral |
| Stochastic | 8.2 | Oversold |
IREN's weekly RSI is 33 (neutral) and its Stochastic is 8 (oversold).
C PE vs Financial Services Sector
| Metric | C | Sector median | Relative |
|---|---|---|---|
| PE | 12x | 13x | 7.2% below |
| PE % | 60 | 63 | 3 pts below |
C is trading at 12x earnings, in line with the Financial Services sector's median of 13x.
IREN PE vs Financial Services Sector
| Metric | IREN | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 13x | — |
IREN has no meaningful PE right now: it lost money over the past year.
C Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $125.4 | 1.1% below |
| 20 week MA | $131.3 | 5.5% below |
| 50 week MA | $124.8 | 0.6% below |
| 100 week MA | $104.4 | 19% above |
| 200 week MA | $79.0 | 57% above |
C has the edge over IREN on trend strength, trading above more of its moving averages.
IREN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $29.8 | 35% below |
| 20 week MA | $36.2 | 46% below |
| 50 week MA | $42.8 | 54% below |
| 100 week MA | $32.0 | 39% below |
| 200 week MA | $19.1 | 2.1% above |
IREN has fallen below most of its moving averages, though it's still 2.1% above its 200-week average.
C Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $79.7 | $60.6 | -24% |
| 2021 | $60.6 | $60.2 | -0.6% |
| 2022 | $60.2 | $44.3 | -26% |
| 2023 | $44.3 | $51.4 | +16% |
| 2024 | $51.4 | $71.0 | +38% |
| 2025 | $71.0 | $120.4 | +70% |
| 2026 YTD | $120.4 | $124.1 | +3% |
C has the edge over IREN on returns for 2026, with the stronger performance.
IREN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $24.8 | $17.2 | -31% |
| 2022 | $17.2 | $1.19 | -93% |
| 2023 | $1.19 | $7.15 | +501% |
| 2024 | $7.15 | $10.7 | +50% |
| 2025 | $10.7 | $40.3 | +276% |
| 2026 YTD | $40.3 | $19.5 | -52% |
IREN's yearly returns have swung widely, from +501% in 2023 to −93% in 2022. It's down 52% so far in 2026.